Profil
Paul Cowan served as Chairman and Chief Executive Officer at Quotient Bioscience Ltd., Pharmaron UK Ltd., and Quotient Ltd. He also served as Chief Financial Officer, Secretary, and Treasurer at Inveresk Research Group, Inc. from 2001 to 2004.
Cowan obtained an undergraduate degree from Queensland University of Technology.
Ehemalige bekannte Positionen von Paul Cowan
| Unternehmen | Position | Ende |
|---|---|---|
| QUOTIENT LIMITED | Vorstandsvorsitzender | 26.03.2018 |
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Finanzdirektor/CFO | 01.01.2004 |
Pharmaron UK Ltd.
Pharmaron UK Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development services | Vorstandsvorsitzender | - |
Quotient Bioscience Ltd.
Quotient Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Offers drug development services | Vorstandsvorsitzender | - |
Ausbildung von Paul Cowan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Queensland University of Technology
Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quotient Bioscience Ltd.
Quotient Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Offers drug development services | Commercial Services |
Pharmaron UK Ltd.
Pharmaron UK Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
Quotient Ltd.
Quotient Ltd. Medical SpecialtiesHealth Technology Develops and manufactures conventional reagent products | Health Technology |
















